Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousBone Marrow TransplantationTransplantation ConditioningHematopoietic Stem Cell MobilizationGraft vs Host DiseaseHematologic NeoplasmsStem Cell TransplantationGranulocyte Colony-Stimulating FactorBone MarrowLeukapheresisAntigens, CD34MelphalanGraft SurvivalCombined Modality TherapyBlood Component RemovalHematopoietic Stem CellsBone Marrow CellsCyclophosphamideBusulfanTissue DonorsTreatment OutcomeMultiple MyelomaTransplantation ChimeraAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsStem CellsWhole-Body IrradiationRecurrenceCord Blood Stem Cell TransplantationHistocompatibilityLeukemiaLymphoma, Non-HodgkinHistocompatibility TestingRemission InductionImmunosuppressive AgentsAntineoplastic Agents, AlkylatingEtoposideAnemia, AplasticHematopoiesisTransplantation, IsogeneicRetrospective StudiesThiotepaCytomegalovirus InfectionsDisease-Free SurvivalInfectionLeukemia, Myeloid, AcutePOEMS SyndromeTime FactorsSurvival AnalysisSurvival RateBlood CellsVidarabineLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSalvage TherapyHodgkin DiseaseOpportunistic InfectionsAmyloidosisMyelodysplastic SyndromesGraft vs Leukemia EffectFatal OutcomeCytarabinePrecursor Cell Lymphoblastic Leukemia-LymphomaVincristineCyclosporineBone Marrow DiseasesIfosfamideCarmustineImmunosuppressionLymphocyte DepletionBone Marrow PurgingPlatelet CountBone and BonesHematologic DiseasesHLA AntigensLymphomaFollow-Up StudiesBlood Cell CountNeoplasmsKidney TransplantationImmunophenotypingProspective StudiesLiver TransplantationBlood Group IncompatibilityCytophagocytosisAcute DiseaseBlood DonorsT-LymphocytesNuclear FamilyHistiocytosis, Non-Langerhans-CellFeasibility StudiesLeukocyte CountRecombinant ProteinsLivedo ReticularisDoxorubicinPrognosisFlow CytometryMesenchymal Stem Cell Transplantation